Inflammatory Bowel Disease - Testing for the Diagnosis and Management - (0121)

Cigna covers fecal calprotectin (CPT 83993) only to distinguish IBS from IBD in individuals with chronic diarrhea or for management of known IBD and excludes testing for any other indications (all ICD‑10 codes not listed are not covered). Coverage is limited to the specific diagnosis codes listed (e.g., K50.x, K51.x, K58.x, K59.31, R19.7), requires clinical documentation showing one of these indications, and claims without a covered code or appropriate documentation will be denied.

"Fecal calprotectin is considered medically necessary when either of the following criteria is met: for the purpose of distinguishing irritable bowel syndrome (IBS) from inflammatory bowel disease (..."

Sign up to see full coverage criteria, indications, and limitations.